G9063 is a valid 2023 HCPCS Code that could be used to indicate Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) for reimbursement purposes.
G9063 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2007.
Short description for G9063 HCPCS code:
Onc dx nsclc stgi no progres